Professional dialogue is a key factor for the successful functioning of EAEU Common market of medicinal products
On November 15, 2017 the Scientific and Practical International Conference “Common market of medicines within the Eurasian Economic Union - modern trends of medicinal products regulation and enforcement”, unprecedented by its participants, content and discussion on high professional level, was held in Moscow. The Conference gathered high-ranking representatives of the Eurasian Economic Commission (EEC), the European Directorate for the Quality of Medicines (EDQM), the European Medicines Agency (EMA), EAEU Pharmacopoeia Committee, regulatory authorities and expert agencies of all EAEU Member-States, heads of the leading national and international professional associations, industry. The event was organized by the Eurasian Economic Commission (EEC), the Association of International Pharmaceutical Manufacturers (AIPM) and the European Federation of Pharmaceutical Industry and Associations (EFPIA).
A DIALOGUE BETWEEN REGULATORS AND THE PHARMA INDUSTRY ON MODERN GMP INSPECTION STANDARDS
On June 27, 2017 the Association of International Pharmaceutical Manufacturers (AIPM) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), supported by the State Institute of Medicines and Good Practices of the Russian Ministry of Industry and Trade (SIM & GxP), held a scientific and practical Workshop “Modern tendencies in GMP inspections of pharmaceutical manufacturers”. Representatives of regulatory authorities and expert organizations from Russia and Kazakhstan, representatives of headquarters and Russian branches of international pharmaceutical companies as well as recognized international experts participated in this discussion.
Introducing company interests, on which share it is necessary about 80 % made and sold in the world of pharmaceutical production and the medical equipment, AIPM considers as the priority cooperation with the Russian bodies of public health services, and also with legislative and executive branches of the power, for the purpose of working out of the program of creation of favorable conditions for sale and-or production of the international pharmaceutical companies in territory of the Russian Federation